These assays showed that the nine selected lncRNAs (LINC00900, MIR210HG, MIR22HG, PVT1, SNHG18, HAR1A, LINC00641, SLC25A21-AS1, and SNAI3-AS1) were expressed to different extents in NBT, LGG, and GBM tissues at the mRNA level (Figure 8a–i), in accordance with the bioinformatics results. This evidence concerns the gene HAR1A and glioblastoma.